KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Research & Development (2016 - 2025)

Idexx Laboratories (IDXX) has 17 years of Research & Development data on record, last reported at $66.8 million in Q4 2025.

  • For Q4 2025, Research & Development rose 15.77% year-over-year to $66.8 million; the TTM value through Dec 2025 reached $251.2 million, up 14.29%, while the annual FY2025 figure was $251.2 million, 14.29% up from the prior year.
  • Research & Development reached $66.8 million in Q4 2025 per IDXX's latest filing, up from $63.4 million in the prior quarter.
  • Across five years, Research & Development topped out at $123.2 million in Q2 2022 and bottomed at $37.6 million in Q1 2021.
  • Average Research & Development over 5 years is $53.9 million, with a median of $49.9 million recorded in 2022.
  • Peak YoY movement for Research & Development: skyrocketed 226.87% in 2022, then tumbled 62.26% in 2023.
  • A 5-year view of Research & Development shows it stood at $45.3 million in 2021, then dropped by 4.17% to $43.4 million in 2022, then increased by 19.33% to $51.8 million in 2023, then increased by 11.42% to $57.7 million in 2024, then increased by 15.77% to $66.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Research & Development were $66.8 million in Q4 2025, $63.4 million in Q3 2025, and $61.9 million in Q2 2025.